Category
Press Release
-
2026
-
W. R. Berkley Corporation Increases Share Repurchase Authorization
-
State Street Supports Columbia Threadneedle UCITS ETF Launch
-
Duke Energy to announce fourth-quarter and year-end 2025 financial results on Feb. 10
-
National Advertising Division Finds Certain T-Mobile Claims Supported, Recommends Modifications to Others; T-Mobile to Appeal
-
Exelon Names Tim Peterson Chief Customer and Technology Officer
-
NDEX Systems Announces New Integrated Single Sign-On and Streamlined Client Onboarding Experience with Schwab Advisor Center®
-
Zifo at JPM Healthcare Conference 2026: Why Technology Alone Cannot Deliver the AI Promise
-
Encoded Therapeutics Highlights Progress in Dravet Syndrome Program and Pipeline Ahead of Company Presentation at 44th Annual J.P. Morgan Healthcare Conference
-
AI Investment Accounted for Nearly Half of Healthcare Investment in 2025; Silicon Valley Bank Releases 17th Healthcare Investments and Exits Report
-
Diana Shipping Inc. Announces Direct Continuation of Time Charter Contract for m/v Maia with Paralos Shipping
-
Majority of Gen X Feels Confident in Their Investment Decisions, Yet 40% Lack a Formal Financial Plan
-
UMB Announces Conference Call to Discuss Fourth Quarter 2025 Results
-
Bounty Returns as the Ultimate Wingman – Tackling Gameday Messes from Playoffs to Super Bowl LX
-
Lumen Technologies, Inc. Announces Expiration and Results of Previously Announced Tender Offers and Consent Solicitations
-
Immorta Bio Doubles Mouse Lifespan Using Combination Senolytic and Regenerative Therapy in Validated Aging Models
-
NewtekOne, Inc. Posts Investor Day Presentation and Provides 2026 EPS Guidance Range of $2.15-$2.55
-
TPG to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Investor Call
-
32 Biosciences to Launch $40 Million Series A at J.P. Morgan to Advance First-in-Class GI Mucosal-Immune Therapeutics
-
ClearBridge Energy Midstream Opportunity Fund Inc. Announces Unaudited Balance Sheet Information as of December 31, 2025
-
Avenacy Provides Update on Business Progress and Announces 2026 Strategic Priorities Ahead of 44th Annual J.P. Morgan Healthcare Conference
-
Flare Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Abacus Global Management Chairman and CEO Jay Jackson Releases Shareholder Letter
-
CareCloud Brings Wellsoft to Urgent Care with Affinity Deal, Targeting a Larger Nationwide Market Opportunity
-
Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook